Header Logo

Connection

DAVID ROWLEY to Cisplatin

Back to Details
This is a "connection" page, showing publications DAVID ROWLEY has written about Cisplatin.
DAVID ROWLEY
Connection Strength
0.012
Cisplatin
  1. Combination of adenovirus-mediated thymidine kinase gene therapy with cytotoxic chemotherapy in bladder cancer in vitro. Urol Oncol. 2003 May-Jun; 21(3):197-205.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.